| Rapid epidemic expansion of the SARS-CoV-2 Omicron variant in southern Africa R Viana, S Moyo, DG Amoako, H Tegally, C Scheepers, CL Althaus, ... Nature 603 (7902), 679-686, 2022 | 1407 | 2022 |
| Emergence of SARS-CoV-2 omicron lineages BA. 4 and BA. 5 in South Africa H Tegally, M Moir, J Everatt, M Giovanetti, C Scheepers, E Wilkinson, ... Nature medicine 28 (9), 1785-1790, 2022 | 514 | 2022 |
| Human immunodeficiency virus type 1 subtype C molecular phylogeny: consensus sequence for an AIDS vaccine design? V Novitsky, UR Smith, P Gilbert, MF McLane, P Chigwedere, C Williamson, ... Journal of virology 76 (11), 5435-5451, 2002 | 197 | 2002 |
| Enabling the genomic revolution in Africa: H3Africa is developing capacity for health-related genomics research in Africa H3Africa Consortium Science (New York, NY) 344 (6190), 1346, 2014 | 191 | 2014 |
| Universal testing, expanded treatment, and incidence of HIV infection in Botswana J Makhema, KE Wirth, M Pretorius Holme, T Gaolathe, M Mmalane, ... New England Journal of Medicine 381 (3), 230-242, 2019 | 189 | 2019 |
| A year of genomic surveillance reveals how the SARS-CoV-2 pandemic unfolded in Africa E Wilkinson, M Giovanetti, H Tegally, JE San, R Lessells, D Cuadros, ... Science 374 (6566), 423-431, 2021 | 185 | 2021 |
| High prevalence of the K65R mutation in human immunodeficiency virus type 1 subtype C isolates from infected patients in Botswana treated with didanosine-based regimens F Doualla-Bell, A Avalos, B Brenner, T Gaolathe, M Mine, S Gaseitsiwe, ... Antimicrobial agents and chemotherapy 50 (12), 4182-4185, 2006 | 138 | 2006 |
| Maternal single-dose nevirapine versus placebo as part of an antiretroviral strategy to prevent mother-to-child HIV transmission in Botswana RL Shapiro, I Thior, PB Gilbert, S Lockman, C Wester, LM Smeaton, ... Aids 20 (9), 1281-1288, 2006 | 134 | 2006 |
| H3ABioNet, a sustainable pan-African bioinformatics network for human heredity and health in Africa NJ Mulder, E Adebiyi, R Alami, A Benkahla, J Brandful, S Doumbia, ... Genome research 26 (2), 271-277, 2016 | 116 | 2016 |
| Highly active antiretroviral therapy started during pregnancy or postpartum suppresses HIV-1 RNA, but not DNA, in breast milk RL Shapiro, T Ndung’u, S Lockman, LM Smeaton, I Thior, C Wester, ... The Journal of infectious diseases 192 (5), 713-719, 2005 | 113 | 2005 |
| Continued emergence and evolution of Omicron in South Africa: New BA. 4 and BA. 5 lineages H Tegally, M Moir, J Everatt, M Giovanetti, C Scheepers, E Wilkinson, ... MedRxiv, 2022.05. 01.22274406, 2022 | 106 | 2022 |
| African-led health research and capacity building-is it working? VO Kasprowicz, D Chopera, KD Waddilove, MA Brockman, J Gilmour, ... BMC Public Health 20, 1-10, 2020 | 106 | 2020 |
| Pattern recognition in pulmonary tuberculosis defined by high content peptide microarray chip analysis representing 61 proteins from M. tuberculosis S Gaseitsiwe, D Valentini, S Mahdavifar, I Magalhaes, DF Hoft, J Zerweck, ... PloS one 3 (12), e3840, 2008 | 92 | 2008 |
| The reverse transcriptase 67N 70R 215Y genotype is the predominant TAM pathway associated with virologic failure among HIV type 1C-infected adults treated with ZDV/ddI … V Novitsky, CW Wester, V DeGruttola, H Bussmann, S Gaseitsiwe, ... AIDS research and human retroviruses 23 (7), 868-878, 2007 | 88 | 2007 |
| The evolving SARS-CoV-2 epidemic in Africa: Insights from rapidly expanding genomic surveillance H Tegally, JE San, M Cotten, M Moir, B Tegomoh, G Mboowa, DP Martin, ... Science 378 (6615), eabq5358, 2022 | 86 | 2022 |
| Point-of-care Cepheid Xpert HIV-1 viral load test in rural African communities is feasible and reliable S Moyo, T Mohammed, KE Wirth, M Prague, K Bennett, MP Holme, ... Journal of clinical microbiology 54 (12), 3050-3055, 2016 | 82 | 2016 |
| HIV-1 subtype C in vitro growth and coreceptor utilization T Ndung'u, E Sepako, MF McLane, F Chand, K Bedi, S Gaseitsiwe, ... Virology 347 (2), 247-260, 2006 | 64 | 2006 |
| Peptide Microarray-Based Identification of Mycobacterium tuberculosis Epitope Binding to HLA-DRB1*0101, DRB1*1501, and DRB1*0401 S Gaseitsiwe, D Valentini, S Mahdavifar, M Reilly, A Ehrnst, M Maeurer Clinical and Vaccine Immunology 17 (1), 168-175, 2010 | 62 | 2010 |
| An early warning system for emerging SARS-CoV-2 variants L Subissi, A von Gottberg, L Thukral, N Worp, BB Oude Munnink, ... Nature medicine 28 (6), 1110-1115, 2022 | 61 | 2022 |
| Mycobacterium tuberculosis next-generation whole genome sequencing: opportunities and challenges T Iketleng, R Lessells, MT Dlamini, T Mogashoa, L Mupfumi, S Moyo, ... Tuberculosis research and treatment 2018, 2018 | 50 | 2018 |
